Lastly, investigations show wide-ranging frequencies of EGFR amplification (39–71 %) as well as LOH of 10q (0–58 %) highlighting the molecular heterogeneity seen in GBM-O [2, 3, 6, 42]. This evidence concerns the gene EGFR and glioblastoma.